Section Arrow
RVMD.NASDAQ
- Revolution Medicines
Quotes are at least 15-min delayed:2025/08/31 22:39 EDT
Regular Hours
Last
 37.97
-0.355 (-0.93%)
Day High 
38.6924 
Prev. Close
38.325 
1-M High
39.54 
Volume 
1.94M 
Bid
37.25
Ask
38.1
Day Low
37.56 
Open
38.32 
1-M Low
34 
Market Cap 
7.16B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 36.83 
20-SMA 36.46 
50-SMA 37.37 
52-W High 62.4 
52-W Low 29.17 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.52/-6.05
Enterprise Value
7.29B
Balance Sheet
Book Value Per Share
9.98
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.14
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CARMCarisma Therapeutics0.215-0.013-5.70%-- 
TNFATNF Pharmaceuticals Inc.0.0483-0.0133-21.59%-- 
ADAPAdaptimmune Therapeutics plc0.0589-0.01-14.51%-- 
SRPTSarepta Therapeutics18.2-0.14-0.76%15.76PE
OTLKOutlook Therapeutics0.8512-0.2388-21.91%0.58PE
Quotes are at least 15-min delayed:2025/08/31 22:39 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.